Member Log-in

I forgot my password

Not a Member? Register


Our resource library is a searchable collection of tools and documents related to various technical areas around the Gavi transition. The library consists of research articles, policy briefs, reports, guidebooks, country data, and other resources pertinent to Gavi transition or immunization programs generally. You can filter the resources by topic, type, or country. 


Results 31 - 40 of 39

Countries Transitioning From Donor Health Aid – Best Practices and Next Steps

In this blog post, Robert Hecht and Sarah Bennet describe global health transitions and explain the reasons why they are happening now; point to the risks inherent in the transition process; highlight emerging best practices as well as weak and neglected areas; outline what we see as an emerging analytical agenda; and propose next steps to make such an agenda and more coordinated action across countries and donor agencies a reality.


Gavi’s Transition Policy: Moving From Development Assistance To Domestic Financing Of Immunization Programs

This article discusses some of the challenges facing countries currently transitioning out of Gavi support, how Gavi’s policies have evolved to help manage the risks involved in this process, and the lessons learned from this experience.

Country Ownership And Gavi Transition: Comprehensive Approaches To Supporting New Vaccine Introduction

Since the mid-2000s low- and lower-middle-income countries have been focusing on developing and using evidence for immunization policy making, with an increasing emphasis on cost-effectiveness analysis, program costing, and financial flows—particularly for the introduction of newer, more expensive vaccines. While this is critical to informing decisions, countries still need to increase national immunization investment and explore innovative approaches to augment financing of immunization programs.


Overcoming Challenges to Sustainable Immunization Financing

Sixteen countries are currently scheduled to ‘graduate’ from GAVI assistance by 2018. Five of these countries were chosen for ‘transition planning’ support from GAVI and other partners in 2012. Through country assessments, a variety of challenges were identified in transitioning away from GAVI assistance towards national self-sufficiency, including concerns relating to financial sustainability, sound procurement practices, effective national regulatory agencies,

File size: 172.53K

An Analysis Of How The GAVI Alliance And Low- And Middle-Income Countries Can Share Costs Of New Vaccines

Immunization is one of the “best buys” in global health. However, for the poorest countries, even modest expenditures may be out of reach. The GAVI Alliance is a public-private partnership created to help the poorest countries introduce new vaccines. Since 2008 GAVI has required that countries cover a share of the cost of vaccines introduced with GAVI support.

File size: 381.54K

Sustaining GAVI-supported Vaccine Introductions in Resource-poor Countries

Since 2000, GAVI provided essential support for an unprecedented increase in the use of hepatitis B (HepB) and Haemophilus influenzae (Hib) containing vaccines in resource poor countries. This increase was supported with significant funding from international donors, intended to be time-limited. To assess the sustainability of this important expansion of the global access to vaccines, the authors of this article reviewed supply chains, financial resources for procurement and decision-making in countries that introduced hepatitis B or Hib vaccines with GAVI support.

Choose a Language